FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection
Main Authors: | Zhe Li, Shuai Wang, Fangfang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-03-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-023-01390-y |
Similar Items
-
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
by: Brevini, T, et al.
Published: (2022) -
UDCA, a novel strategy for preventing SARS-CoV-2 infection via FXR-mediated ACE2 downregulation
by: Chen Mengjiao, et al.
Published: (2023-04-01) -
Anthracyclines inhibit SARS-CoV-2 infection
by: Zhen Wang, et al.
Published: (2023-09-01) -
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2
by: Zhenzhen Wang, et al.
Published: (2024-03-01) -
Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
by: Kim Tien Ng, et al.
Published: (2021-02-01)